PERRIGO Co plc (PRGO)
Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: Ireland
Exchange: NYSE
Market cap: $1.88B
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Latest financial period: June 27, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 4, 2026
Profit #1411 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | -11.6% | -11.4% | -8.4% | 1.8% |
Growth #1425 of 1484 companies
Payout #1117 of 1484 companies
Safety #1129 of 1484 companies
Price #1049 of 1484 companies
